✦ LIBER ✦

Combined gemcitabine and CHK1 inhibitor treatment induces apoptosis resistance in cancer stem cell-like cells enriched with tumor spheroids from a non-small cell lung cancer cell line

✍ Scribed by Douglas D. Fang, Joan Cao, Jitesh P. Jani, Konstantinos Tsaparikos…

Book ID: 120947182
Publisher: Springer-Verlag
Year: 2013
Tongue: English
Weight: 917 KB
Volume: 7
Category: Article
ISSN: 2095-0217
DOI: 10.1007/s11684-013-0270-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re-expression of TSLC1 in a non-small-ce

Re-expression of TSLC1 in a non-small-cell lung cancer cell line induces apoptosis and inhibits tumor growth

✍ Mao, Xinliang; Seidlitz, Eric; Truant, Ray; Hitt, Mary; Ghosh, Hara P 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 550 KB

Prospective phase II trial of a combinat

Prospective phase II trial of a combination of gemcitabine and UFT as first-line treatment in elderly patients with advanced non-small cell lung cancer

✍ Baek, Jin Ho; Kim, Hawk; Ahn, Jong-Joon; Jegal, Yangjin; Seo, Kwang Won; Ra, Seu 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 258 KB

First-Line Chemotherapy with Vinorelbine

First-Line Chemotherapy with Vinorelbine, Gemcitabine, and Carboplatin in the Treatment of Brain Metastases from Non-Small-Cell Lung Cancer: A Phase II Study

✍ Bernardo, Giovanni; Cuzzoni, Quinto; Strada, Maria Rosa; Bernardo, Antonio; Brun 📂 Article 📅 2002 🏛 Informa plc 🌐 English ⚖ 129 KB

CD80 expression in an HLA-A2-positive hu

CD80 expression in an HLA-A2-positive human non-small cell lung cancer cell line enhances tumor-specific cytotoxicity of HLA-A2-positive T cells derived from a normal donor and a patient with non-small cell lung cancer

✍ Dale L. Bixby; John R. Yannelli 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 185 KB 👁 2 views

To generate non-small cell lung cancer (NSCLC)-reactive lymphocytes, we transfected an HLA-A2-expressing human NSCLC line (1355) with the cDNA encoding the lymphocyte co-stimulatory molecule CD80. Following selection in G418, 1355.7 demonstrated stable cell-surface expression of CD80. Allogeneic mix

9095 POSTER Prospective Phase II Trial o

9095 POSTER Prospective Phase II Trial of a Combination of Gemcitabine and UFT as First-line Treatment in Elderly Patients With Advanced Non-small Cell Lung Cancer

✍ Baek, J.; Ahn, J.; Jegal, Y.; Park, C.; Lee, Y.; Cha, H.; Kwon, W.; Noh, Y.; Par 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Gefitinib does not improve survival when

Gefitinib does not improve survival when combined with gemcitabine and cisplatin in people with advanced non-small-cell lung cancer: Abstracted from: Giaccone G, Herbst RS, Manegold C et al. Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial-INTACT 1. J Clin Oncol 2004;22:777–784.

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 212 KB